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1. Introduction
  Radiation pneumonitis refers to the inflammatory reaction 
caused by injuries of the normal lung tissue within the 
radiation field after radiotherapy of lung cancer, esophageal 
cancer, breast cancer, malignant lymphoma or other chest 
and neck tumors. Usually, irritating dry cough appears as 
the main symptom of acute patients[1], while for chronic 
patients, lung infection can be easily stimulated due to their 
weak immunity, further generating extensive lung fibrosis[2] 
and causing damage of the respiratory function and 
even lethal respiratory failure. Clinically, adrenocortical 
hormone is more often used for the treatment of radiation 
pneumonitis[3] with good curative effects but many side 
effects. Currently, there is still no effective means to prevent 
and treat acute and chronic radiation lung injury.
  Human umbilical cord mesenchymal stem cells (hUC-
MSCs) are a kind of stem cell characterized by self-
renewal, proliferation and multi-directional differentiation 
potency[4]. Presently, it is widely used for the treatment of 
multiple organ injury[5] clinically with the advantages of 
convenience, extensive sources, sufficient quantity, low 
immunogenicity, no ethical controversy, fast proliferation, 
strong differentiation ability and extensive application 
prospect. In this experiment, the curative effect of hUC-
MSCs on rat acute radiation pneumonitis was observed, 
providing a clinical basis for the prevention and treatment 
of radiation-induced diseases.
Objective: To evaluate of the curative effect of human umbilical cord mesenchymal stem cells 
(hUC-MSCs) on rat acute radiation pneumonitis. Methods: Fourty rats were randomly divided 
into control group, radiation group, stem cell prevention group, stem cell treatment group and 
prednisone treatment group. All rats except those in the control group were radiated with X ray 
to establish the acute radiation pneumonitis damage model. The hUC-MSCs cultured in vitro was 
administrated to the rats of the prevention group via tail vein (1×106 cells/kg BW) 24 h before the 
radiation, while the same administration was performed in the rats of the treatment group 24 h 
after the radiation. After 24 h post the radiation, the rats in the radiation group were given 0.4 mL 
physiological saline, and those in the prednisone group were given 1 mg/kg prednisone. All rats 
were observed and executed 72 h after the radiation to detect lung histological changes. Results: 
After the administration of hUC-MSCs, the survival status of the rats in the prevention group and 
treatment group was obviously better than that in the control group. As shown by the histological 
staining, the morphology, proliferation activity and bronchial state of lung tissues were better in 
the prevention group and treatment group than in the control group. Conclusion: The hUC-MSCs 
have definite therapeutic effects on acute radiation pneumonitis in rats.
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2.  Materials and methods
2.1. Materials
  Mouse anti-human CD34-PE, CD45-PE, CD29-PE, CD44-
PE, CD73-PE, CD90-PE, and CD105-PE antibodies were 
purchased from American Cell Signaling Technology Co., 
Ltd. The Swedish Elekta Precise linear accelerator and 
FACSCanto II flow cytometer were purchased from Becton 
Dickinson Medical Instrument Co., Ltd. TCS-SPZ inverted 
fluorescence confocal microscopy was purchased from 
German Leica Company.
2.2. Animal grouping and radiation
  Fourty healthy male Wistar rats at the age of 2 months and 
with weight of (200±20) g were provided by the Laboratory 
Animal Research Center of Shandong University and 
randomly divided into five groups, namely, the control 
group, radiation group, stem cell prevention group, stem cell 
treatment group and prednisone treatment group, eight rats 
in each group.
  The rats except those in the control group were fixed on 
the plastic foam board by rubber bands, with chest exposed. 
They were given chloral hydrate (4-5 mL/kg BW) for 
peritoneal injection anesthesia. The Swedish Elekta Precise 
linear accelerator (X-ray) was used for irradiation performed 
under the following conditions: source skin distance, 120 
cm; absorbed dose rate, 300 mu/min; radiation field, 10 cm × 20 
cm; X-ray energy, 6 mv; and total effective biological dose, 
8 GY[6].
  
2.3. In vitro culture of hUC-MSCs
  The hUC-MSCs were cultured in vitro[7]. In this aseptic 
operation, 30-40 cm long healthy neonatal umbilical 
cord was put into aseptic saline solution containing 0.1% 
penicillin and streptomycin. Before the experiment, the 
umbilical cord was rinsed with 75% (v/v) ethanol and cut 
into 1.5-2.0 cm pieces. After peeling of umbilical cord 
skin and artery blood vessel, these pieces were washed 
2-3 times in the saline solution, cut into pieces, and then 
put into a centrifuge tube. Then, 2 times volume of 0.2% 
Type I collagen enzyme and 100 毺L of 0.1% penicillin and 
streptomycin were added, followed by overnight digestion at 
37 曟. In the next morning, 2.5 g/L trypsin with 0.5 g/L EDTA 
was added, followed by further digestion for 30 min with 37 
曟. Subsequently, the digestion products were fully diluted 
with 8 times volume of saline solution, mixed well and put 
into centrifuge tubes separately, followed by centrifugation 
at 3 000 r/min for 20 min. They were washed again with 
normal saline and centrifuged at 2 000 r/min for 10 min. 
The supernatants were discarded and the cell pellet was 
resuspended in a certain amount of culture medium.
  The cells were inoculated at a density of 1×106 cells /cm2 and 
incubated in 5% (v/v) CO2 at 37 曟. Digestion and passage 
were performed when the convergence area reached 90%. 
The mixture containing PBS and 2.5 g/L trypsin with 0.5 g/L 
EDTA at a volume ratio of 1:4 was used for digestion. When 
most of the cells became round, culture medium was added 
to stop digestion. The cell suspension was transferred into 
centrifuge tubes and centrifuged at 1 500 r/min for 10 min. 
Then, the cells were collected and diluted with culture 
medium for cell count. The cells were inoculated at a density 
of 3 000-6 000 cells/cm2 in an ncubator with 5% (v/v) CO2 at 
37 曟. Generally, the cells of the first five generations were 
used for the experiment.
2.4. Flow cytometry
  After digestion, the hUC-MSCs suspension was centrifuged 
at 1 300 r/min for 8 min. Then the cells were resuspended in 
PBS and made into single cell suspension by gently blowing. 
Later, 15 毺L of mouse anti-human CD34-PE, CD45-
PE, CD29-PE, CD44-PE, CD73-PE, CD90-PE and CD105-
PE antibody were added into each tube containing 50 毺L 
single cell suspension respectively and incubated at room 
temperature in darkness for 30 min. Then, 1 mL PBS was 
added into each tube and centrifugated at 1 500 r/min for 6 
min. After removal of the supernatants, 2 mL PBS was added 
into each tube and centrifugated again at 1 500 r/min for 6 
min. After the supernatants were discarded, the cell pellets 
were finally resupended in 400 毺L PBS and detected by 
flow cytometry.
  
2.5. Administration and observation
  The rats in the stem cell prevention group were injected 
with 0.4 mL of hUC-MSCs suspension (1×106 cells/kg 
BW) via tail vein 24 h before the radiation, while the 
same administration was done in the rats of the stem cell 
treatment group 24 h after the radiation. The rats in the 
radiation group and prednisone treatment group were given 
normal saline (0.4 mL per rat) and prednisone (1 mg/kg.d) via 
tail vein 24 h after the radiation, respectively. 
  The rats were fed in separate cages under the same 
conditions, and their mental states and manure were 
observated. They were weighted and killed 72 h after 
radiation. Under aseptic conditions, the right lung 
tissue was selected to make slices for HE staining and 
immunohistochemical staining, and the results were 
observed under an inverted microscope.
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3. Results
3.1. Morphological observation of hUC-MSCs
  As observed under the inverted microscope, the hUC-
MSCs became adherent after 1 d post the inoculation, and 
more adherent cells appeared on the 2nd day. After removal 
of suspension cells, the adherent cells began to proliferate 
on the 3rd day and spread into elliptic, short shuttle-like, 
polygonal and irregular type (Figure 1). On the 14th day, 
the cells concentrated in the colony center and overspread 
the bottle bottom. The 3rd-5th generations of cells showed 
a uniform long shuttle-like type and arranged in a spiral 
or radical pattern (Figure 2), which were the typical 
morphological features of mesenchymal stem cells. 
A                                                                      B
Figure 1. Human umbilical cord mesenchymal stem cells cultured in 
vitro (伊100).   
(A) Day 3 of the first generation. (B) The 3rd generation. 
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Figure 2. Positive expression rate of CD molecules of mesnchymal 
stem cells.
3.2. Identification of mesnchymal stem cells
  The low expression of CD34, negative expression of 
CD45, and positive expression of CD29, CD44, CD73, CD90 
and CD105 were observed in the isolated hUC-MSCs, as 
detected by flow cytometry (Figure 3).
A                                                   B
C                                                 D                                               E
Figure 3. Lung tissue of rats (HE staining, 伊100). 
(A) Control group; (B) Radiation group; (C) Stem cell prevention group; 
(D) Stem cell treatment group; (E) Prednisone treatment group. 
3.3. Macroscopic observations of experimental animals 
  After the radiation, one rat suffered from tachypnea and 
died after 4 h. On the 1st day after radiation, the rats in the 
stem cell prevention group and treatment group respired 
normally and had the best mental status, with increased diet 
and drink, active action and fighting phenomenon. These 
rats bit the glove when being taken from the cages and they 
had bright eyes and swift response, while the rats in other 
groups had sleepiness and discharged thin stool. On the 2nd 
day after radiation, the rats in the stem cell prevention group 
and treatment group showed good mental status. No obvious 
changes except thin stool were found in the prednisone 
treatment group, while the rats in other groups still had 
sleepiness. On the 3rd day after radiation, the rats in each 
group had thin stool, which was more serious in the radiation 
group. All rats had varying yellow hairs on their backs and 
tail skin shedding with irregular white spots, but the rats in 
the treatment group showed the best mental status. Totally, 
72 h after the radiation, the number of dead rats in the 
control group, radiation group, stem cell prevention group, 
stem cell treatment group and prednisone treatment group 
was 1, 2, 0, 1, and 2, repectively. Remarkable weight loss 
was observed in the radiation group but not in other groups. 
3.4. Efficacy of hUC-MSCs against radiation pneumonitis
  Compared with the normal lungs, the rat which 
died on the day of radiation had an obviously larger 
volume, more surface exudates after longitudinal cut, 
scattered hemorrhagic spots and pulmonary edema. 
After simultaneous perfusion, all rats except those in the 
control group had a small amount of pleural effusion. As 
shown by HE staining, the rats in the control group had 
normal alveolar size and shape, no congestive edema and 
inflammatory infiltration in bronchial mucus membrane, 
and no secretion in the tube (Figure 4A). The rats in the 
radiation group had abnormal alveolar size and shape, 
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massive local inflammatory infiltration, small local abscess 
and peripheral hyperplasia of fibrous tissue (Figure 4B). The 
rats in the prevention group had mostly normal alveolar size 
and shape, local alveolar ectasia, dilation and congestion of 
bronchial wall and lung interstitial vessels, and no secretion 
in the bronchial lumen (Figure 4C). The rats in the treatment 
group had relatively normal alveolar size and shape, mild 
congestion and edema of bronchial wall and lung interstitial, 
and small inflammatory infiltration around the bronchial 
(Figure 4D). The rats in the prednisone treatment group 
had mostly normal alveolar size and shape, local alveolar 
ectasia, mild dilation and congestion of bronchial wall and 
lung interstitial, and no obvious secretion in the bronchial 
lumen (Figure 4E).
 
4. Discussion
  In recent years, the incidence of lung cancer and other 
thoracic and neck tumors have been remaining at a 
high level, leading to an increasing number of patients 
with radiotherapy induced acute or chronic radiation 
pneumonitis[8]. Presently, adrenocortical hormone is mostly 
used for the prevention and treatment of acute or chronic 
radiation pneumonitis clinically, and it is very effective 
in the early stage of disease to reduce damages of alveolar 
epithelial cells and microvessel as well as lung tissue 
exudation and edema[9]. Our research indicated that the 
rats in the prednisone group presented better mental status 
and had mostly normal alveoli, local alveolar ectasia and no 
obvious secretion in the bronchial lumen as shown by lung 
histological staining. Although the treatment showed good 
curative effects, hormone therapy often causes osteoporosis 
and other side effects[10,11]. Therefore, it is unfavorable 
for prophylaxis or long-term use. At present, atomized 
inhalation is more often adopted for hormone therapy and 
can remarkably alleviate symptoms and reduce side effects. 
Cyclophosphamide[12] and methotrexate[13] are widely used. 
Surgical treatment is also considered but with less clinical 
use for its poor curative effect[14]. With the development 
of the modernization of traditional Chinese medicines, 
researches about the preventive effects of herbal medicines 
on radiation damage have been progressing around the 
world. Radix isatidis[15], Cordyceps sinensis[16] and Chinese 
herb extracts like quercetin[17], lycopene[18] and curcumin[19] 
show good radioprotection effects.
  Currently, researches on stem cell and regenerative 
medicine have become the most eye-catching area in 
natural science[20]. Adoption of stem cell therapy has many 
advantages like low toxicity or nontoxicity. Preferable 
therapeutic effects can also be achieved without completely 
knowing the exact pathogenesis of the disease. Autologous 
stem cell transplantation can avoid the immunological 
rejection. A lot of studies confirm that hUC-MSCs can be 
induced to differentiate into various adult cells[21]. In vivo, 
stem cells can be differentiated into endothelial cells, 
dopaminergic neurons, skeletal muscle cells, islet cells, 
etc[22-26]. In vitro, they can be differentiated into osteocytes, 
chondrocytes, hepatocytes and myocardial cells, etc[27-29], 
and they have amazing effect on the diseases that cannot be 
well treated with traditional therapy.
  In our study, the injection of a certain amount of 
mesenchymal stem cells before the radiation could alleviate 
the radiative damages to the alveolar endothelial cell and 
small vessels, thus reducing the acute complications after 
radiation. In this experiment, no obvious difference was 
found in curative effects between the treatment group and 
hormonal treatment group, and the effect in the prevention 
group was not as good as that in the stem cell treatment 
group and prednisone treatment group but was better than 
that in the radiation group, indicating an important role of 
stem cells in preventative treatment. The analysis of the 
pathological sections showed that the stem cells could repair 
and replace the injured alveolar epithelial cells to alleviate 
the pulmonary edema and pulmonary arterial hypertension, 
and it is effective in the treatment of radiation pneumonitis 
with no poisonous side effect, compared with hormone 
therapy. Stem cells bring a new hope to the prevention 
therapy of radiation pneumonitis, but the clinical time and 
dose of administration still need studies because of the 
inactivation effect of radials on stem cells. 
  In conclusion, the hUC-MSCs was effective in preventing 
and treating radioactive pneumonia in Wistar rats. The 
administration of stem cells after radiation was more 
effective on the treatment of radiation pulmonary injury and 
on the alleviation of acute pulmonary edema, even curing 
radiation pneumonitis to some extent. Stem cells could 
secrete various repairing factors with lasting effect during 
the culture and survival post in vivo implantation, but the 
specific factors and their roles needs further studies.
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